<code id='7B697B4D79'></code><style id='7B697B4D79'></style>
    • <acronym id='7B697B4D79'></acronym>
      <center id='7B697B4D79'><center id='7B697B4D79'><tfoot id='7B697B4D79'></tfoot></center><abbr id='7B697B4D79'><dir id='7B697B4D79'><tfoot id='7B697B4D79'></tfoot><noframes id='7B697B4D79'>

    • <optgroup id='7B697B4D79'><strike id='7B697B4D79'><sup id='7B697B4D79'></sup></strike><code id='7B697B4D79'></code></optgroup>
        1. <b id='7B697B4D79'><label id='7B697B4D79'><select id='7B697B4D79'><dt id='7B697B4D79'><span id='7B697B4D79'></span></dt></select></label></b><u id='7B697B4D79'></u>
          <i id='7B697B4D79'><strike id='7B697B4D79'><tt id='7B697B4D79'><pre id='7B697B4D79'></pre></tt></strike></i>

          comprehensive

          comprehensive

          author:explore    Page View:528
          Rep. Larry Bucshon (R-Ind.) received a significant amount of campaign donations from the pharmaceutical industry in the second quarter of 2023. House Television via AP

          WASHINGTON — The pharmaceutical industry has been flooding the campaign coffers of Rep. Larry Bucshon, a cardiothoracic surgeon and Republican from Indiana, according to a STAT analysis of this quarter’s filings.

          CEOs of pharmaceutical giants, executives of the brand-drug lobby PhRMA, and companies’ political action committees all gave in higher-than-usual numbers to the rank-and-file House member last quarter. The total was nearly $56,000 between April 14 and June 30.

          advertisement

          Bucshon is a member of the House Energy & Commerce Committee, which works on drug pricing issues, and the GOP Doctors Caucus, but he doesn’t hold leadership positions in either.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          explore

          Moonlake's readout produced a cash windfall. Risks remain
          Moonlake's readout produced a cash windfall. Risks remain

          MollyFerguson/STATFortwodaysstartingonSunday,MoonlakeImmunotherapeuticshappilycrunchednumbersandshar

          read more
          Oak Street deal isn't the answer to health care's woes
          Oak Street deal isn't the answer to health care's woes

          JustinSullivan/GettyImagesCVSHealth’sacquisitionofOakStreetHealth,aMedicare-focusedprimarycareprovid

          read more
          Jerome Adams on the need for new antivirals for Covid
          Jerome Adams on the need for new antivirals for Covid

          PaxlovidtabletsamplesbeinginspectedinFreiburg,Germany.PfizerviaAPTheU.S.Covid-19Public HealthEmergen

          read more

          The public health thinking behind the CDC’s new Covid guidance

          SpencerPlatt/GettyImagesWhatmakesforgoodpublichealthguidance?That’stheconversationIwashavingwithacol